Diagnosis & Disease Information

October 20, 2016

Lartruvo has been sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery alone.

September 20, 2016

The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.

Shirie Leng, MD

May 22, 2015

The FDA and the pharmaceutical industry work hand-in-hand to deliver “lifesaving” drugs to Americans. But whose lives are really being saved?

Next post in White Coat Chronicles

Being a Physician in an Alarm Nation